Zimmer Biomet's share price has been under pressure in recent months due to soft growth, poor cash flows, and higher interest rates. Demographics, the rise of ASCs and technological advancements ...
In the eyes of one medtech executive, the most impressive innovation in the field over the past couple of years “comes down to connection.” In the past, medical device companies operated in silos, ...
Zimmer Biomet, a leader in musculoskeletal health, excels in knee and hip replacements, and surgical robots, making it a sticky choice for many orthopedic surgeons. Competitive advantages include ...
Zimmer Biomet Holdings, Inc. has announced its acquisition of Monogram Technologies Inc. for $4.04 per share in cash, totaling approximately $177 million in equity value. This acquisition will create ...
WARSAW, Ind., Feb. 25, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it will unveil new clinical and operational data and ...
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q2 2025 Earnings Call Transcript August 7, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is $2.07, expectations were $1.98.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results